Abstract
Much like the biological systems it explores, the US biotechnology industry has mechanisms that allow it to change in response to its environment. Terms such as ‘consolidation', ‘downsizing' and ‘restructuring' that were once only used in the context of larger corporations, are now being used to describe the industrial evolution of biotechnology. But exactly how have these changes affected the industry; how are the majority of biotechnology firms faring; what are the different areas of interest for R & D, and how do these sectors vary; and, how does the current structure of the industry affect the future?
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
